CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale Chief Legal Officer sold 3,837 shares at an average $30.03 ($115,222)
- 4 Planned sale See Remarks sold 2,000 shares at $30.01 ($60,016)
- 4 Planned sale Chief Financial Officer sold 5,000 shares at $28.87 ($144,352)
- 4 Planned sale Chief Financial Officer sold 978 shares at $26.40 ($25,819)
- 4 Planned sale Chief Financial Officer sold 4,022 shares at an average $26.38 ($106,105)
- 4 Planned sale Chief Legal Officer sold 5,000 shares at $25.09 ($125,430)
- 4 Planned sale Chief Financial Officer sold 2,500 shares at $25.05 ($62,613)
- 4 Planned sale Chief Legal Officer sold 9,485 shares at $23.00 ($218,178)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Legal Officer sold 3,985 shares at an average $23.02 ($91,729)
- 4 Planned sale Chief Legal Officer sold 500 shares at $23.00 ($11,500)
- 4 Option exercise Chief Financial Officer acquired 8,000 shares (option exercise)
Page 4 of 10 · 197 filings